Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Schedule of Net Income for Purposes of Determining Basic and Diluted EPS Applicable to Common Shares

Net income for purposes of determining basic and diluted EPS applicable to common shares was as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Net income	$	38,089	$	39,153	$	72,830	$	71,695
Income attributable to participating securities	(1,043)		(1,249)		(1,973)		(2,226)
Net income available to common stockholders	$	37,046	$	37,904	$	70,857	$	69,469

Schedule of Basic and Diluted EPS

Basic and diluted EPS were calculated using the following common shares:

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2023	2022	2023	2022
Weighted-average shares for basic EPS	153,214,347	152,700,134	153,114,197	152,643,830
Incremental shares related to stock options and non-vested restricted stock	109,203	263,362	129,085	210,230
Weighted-average shares for diluted EPS	153,323,550	152,963,496	153,243,282	152,854,060

Schedule of Other, Net

Other, net consisted of:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Interest and dividend income	$	4,916	$	935	$	8,851	$	1,385
Net gains (losses) recognized on investment securities	213		(4,130)		207		(7,169)
Net periodic benefit cost other than the service costs	(339)		(237)		(678)		(473)
Other income	1		338		31		2,018
Other, net	$	4,791	$	(3,094)	$	8,411	$	(4,239)

Schedule of Other Assets

Other assets consisted of:

	June 30, 2023		December 31, 2022
Restricted assets	$	1,591	$	25,907
Prepaid pension costs	39,334		38,100
Other assets	37,709		31,310
Total other assets	$	78,634	$	95,317

Schedule of Other Current Liabilities

Other current liabilities consisted of:

	June 30, 2023		December 31, 2022
Accounts payable	$	7,187	$	6,351
Accrued promotional expenses	57,120		56,645
Accrued excise and payroll taxes payable, net	16,683		17,160
Accrued interest	30,305		30,451
Accrued salaries and benefits	5,619		9,614
Allowance for sales returns	10,004		7,526
Other current liabilities	28,820		7,423
Total other current liabilities	$	155,738	$	135,170

Schedule of Cash and Cash Equivalents

The components of “Cash, cash equivalents and restricted cash” in the condensed consolidated statements of cash flows were as follows:

	June 30, 2023		December 31, 2022
Cash and cash equivalents	$	330,323	$	224,580
Restricted cash and cash equivalents included in other current assets	24,899		—
Restricted cash and cash equivalents included in other assets	1,478		25,794
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows	$	356,700	$	250,374

Schedule of Restricted Cash

The components of “Cash, cash equivalents and restricted cash” in the condensed consolidated statements of cash flows were as follows:

	June 30, 2023		December 31, 2022
Cash and cash equivalents	$	330,323	$	224,580
Restricted cash and cash equivalents included in other current assets	24,899		—
Restricted cash and cash equivalents included in other assets	1,478		25,794
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows	$	356,700	$	250,374